FORM 8-K/A-2
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 3, 1998
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-11394 95-3863205
(Commission File Number) (IRS Employer Identification No.)
402 West County Road D
St. Paul, Minnesota 55112
(Address of principal executive offices) (Zip Code)
(612) 636-7466
(Registrant's telephone number, including area code)
<PAGE>
Item 4. Change In Independent Accountants
Effective May 27, 1998, the Registrant terminated Ernst & Young LLP as
its independent accounting firm. Exhibit 16 is the response of Ernst & Young LLP
to the disclosures made by the Registrant on Form 8-K/A dated June 3, 1998.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: June 23, 1998 By: /s/ Peter J. Heath
Name: Peter J. Heath
Title: Vice President of Finance and
Chief Financial Officer
Exhibit 16
ERNST & YOUNG LLP 1400 Pillsbury Center Phone: 612 343 1000
Minneapolis
Minnesota 55402-1491
June 17, 1998
Securities and Exchange Commission
450 Fifth Street NW
Washington, D.C. 2049
Gentlemen:
We have read Item 4 of Form 8-K/A dated June 3, 1998 of Medtox Scientific, Inc.
and are in agreement with the statements contained in the first four paragraphs
of page 2 therein, except as follows:
1. We have no basis to agree or disagree with the second sentence of the
first paragraph of page 2 and,
2. The words "through May 27, 1998" should be placed after the word
"Registrant" in the first line of the fourth paragraph of page 2.
We have no basis to agree or disagree with other statements of the registrant
contained therein.
/s/ Ernst & Young LLP
